Scapho Secukinumab 150 mg Injection

Scapho Secukinumab 150 mg Injection

15500 INR

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Dosage 150 mg
  • Storage Instructions Store In a Cool Palace
  • Supply Ability : 100 Box Box Per Week
  • Click to view more
X

Price And Quantity

  • 10 Box
  • 15500 INR

Product Specifications

  • Injection
  • 150 mg
  • Store In a Cool Palace
  • Liquid

Trade Information

  • Western Union, Telegraphic Transfer (T/T), Letter of Credit at Sight (Sight L/C), Cheque, Cash in Advance (CID), Cash Advance (CA)
  • 100 Box Box Per Week
  • 1 Week
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India

Product Description

WHAT ARE THE POSSIBLE SIDE-EFFECTS OF SCAPHO 150 MG INJECTION ?

diarrhea; or cold symptoms such as stuffy nose, sneezing, sore throat.

Call your doctor at once if you have:

redness, warmth, or swelling under your skin; cold sores, sores on your genital or anal area; painful skin sores; cough, shortness of breath, cough with red or pink mucus; increased urination, pain or burning when you urinate; sores or white patches in your mouth or throat (yeast infection or "thrush"); diarrhea, stomach pain; or fever, chills, sweating, muscle pain, weight loss.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.

WHAT IS SCAPHO 150 MG INJECTION ?

Scapho is an immunosuppressant that reduces the effects of a chemical substance in the body that can cause inflammation.

WHAT IS THE USE OF SCAPHO 150 MG INJECTION ?

Secukinumab is used to treat moderate to severe plaque psoriasis (raised, silvery flaking of the skin) in adults.

 


3S CORPORATION

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.